DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) Free cash flow
DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to DMIIRSource: SEC XBRL filings · For reference only · Not investment advice
More DMIIR financial trends
DMIIR RevenueDMIIR Net incomeDMIIR Net marginDMIIR Gross profitDMIIR Gross marginDMIIR Operating incomeDMIIR Operating marginDMIIR Operating cash flowDMIIR Capital expendituresDMIIR Return on equityDMIIR Stock buybacksDMIIR Dividends paidDMIIR Total assetsDMIIR Total liabilitiesDMIIR Shareholders’ equityDMIIR overview →